(Q35329445)

7 August 2017

1 reference

title

Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders (English)

1 reference

7 August 2017

1 reference

S. M. Grant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379159

20 September 2022

D. Faulds

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379159

20 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1379159

20 September 2022

publication date

1 June 1992

1 reference

7 August 2017

1 reference

7 August 2017

43

1 reference

7 August 2017

873-888

1 reference

7 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199243060-00007

7 August 2017

0 references

cites work

Carbamazepine drug interactions

1 reference

12 December 2020

First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite

1 reference

12 December 2020

Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma

1 reference

12 December 2020

Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepine

1 reference

12 December 2020

Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother

1 reference

12 December 2020

Oxcarbazepine in monotherapy

1 reference

12 December 2020

Established anticonvulsants and treatment of refractory epilepsy

1 reference

12 December 2020

Oxcarbazepine-induced hyponatremia, a cross-sectional study

1 reference

12 December 2020

Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine

1 reference

12 December 2020

Determination of oxcarbazepine in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia

1 reference

12 December 2020

The metabolism of 14C-oxcarbazepine in man

1 reference

12 December 2020

Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepine

1 reference

12 December 2020

Oxcarbazepine disposition: preliminary observations in patients

1 reference

12 December 2020

Hyponatraemia during oxcarbazepine therapy

1 reference

12 December 2020

Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.

1 reference

12 December 2020

In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity

1 reference

12 December 2020

Hyponatraemia during carbamazepine treatment.

1 reference

12 December 2020

Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism

1 reference

12 December 2020

Use of saliva for monitoring oxcarbazepine therapy in epileptic patients

1 reference

12 December 2020

Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication

1 reference

12 December 2020

Induction of microsomal enzymes in rat liver by oxcarbazepine, 10,11-dihydro-10-hydroxy-carbamazepine and carbamazepine

1 reference

12 December 2020

Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites

1 reference

12 December 2020

The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine

1 reference

12 December 2020

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

1 reference

12 December 2020

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects

1 reference

12 December 2020

Implementation of SI units for clinical laboratory data. Style specifications and conversion tables

1 reference

12 December 2020

Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers

1 reference

12 December 2020

Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia

1 reference

12 December 2020

Oxcarbazepine (GP 47 680) in the treatment of intractable seizures

1 reference

12 December 2020

Dose dependent enzyme induction by oxcarbazepine?

1 reference

12 December 2020

Oxcabazepine (®Trileptal) in Anti-epileptic Polytherapy

1 reference

12 December 2020

Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations

1 reference

12 December 2020

Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine?

1 reference

12 December 2020

Side-effects induced by carbamazepine-10,11-epoxide

1 reference

12 December 2020

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

1 reference

12 December 2020

Inhibition or enhancement of kindling evolution by antiepileptics

1 reference

12 December 2020

Trigeminal neuralgia: its treatment with two new carbamazepine analogues

1 reference

12 December 2020

Use of oral contraceptives by women with epilepsy

1 reference

12 December 2020

10.2165/00003495-199243060-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference